Cargando…
Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Immune-Mediated Necrotizing Myopathy following mRNA SARS-CoV-2 Vaccination
The new coronavirus (COVID-19) pandemic has resulted in the unprecedented production of vaccines. In this context, the possible adverse effects remain to be identified and reported. In this article, we report the case of a young female patient who developed anti-3-hydroxy-3-methylglutaryl-coenzyme A...
Autores principales: | Rodrigues de Carvalho, Marta, Sá de Deus Rocha, Myrian Mathildes, Alves Bezerra, Vinícius, de Pontes, Maciel Eduardo, del Negro, Maria Cristina, Antunes, Julio Salgado, Montanaro, Vinícius Viana Abreu, Fernandez, Rubens Nelson Morato |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239300/ https://www.ncbi.nlm.nih.gov/pubmed/37275628 http://dx.doi.org/10.1155/2023/7061783 |
Ejemplares similares
-
Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies
por: Liang, Wen-Chen, et al.
Publicado: (2017) -
Statin-Induced Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase (Anti-HMGCR) Myopathy
por: Ghazal, Fatima, et al.
Publicado: (2023) -
Statin-naïve anti–3-hydroxy-3-methylglutaryl coenzyme A reductase antibody-positive necrotizing myopathy with heliotropic pseudoangioedema
por: Ortiz, Camila, et al.
Publicado: (2022) -
Case report: Diagnostic clues for anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase myopathy in pediatric patients
por: Watanuki, Keisuke, et al.
Publicado: (2023) -
Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory Myopathies
por: Ge, Yongpeng, et al.
Publicado: (2015)